MAPK Signaling(MAPK信号通路)

Products for MAPK Signaling
- ERK(90)
- MEK1/2(64)
- NKCC(6)
- MNK(10)
- PKA(53)
- p38(100)
- Rac(2)
- Raf(68)
- RasGAP (Ras- P21)(1)
- JNK(60)
- cAMP(35)
- Protein Kinase G(2)
- RSK(32)
- Other(4)
- MAPKAPK(1)
- MKK(2)
- KLF(3)
- MAP3K(20)
- MAP4K(25)
- MAPKAPK2 (MK2)(9)
- Mixed Lineage Kinase(10)
- Cat.No. 产品名称 Information
-
GC72124
CREBtide TFA
CREBtide TFA是一种类似CREB (cAMP反应元件结合蛋白)的肽。
-
GC43332
Cuspin-1
Chemical Upregulator of SMN Protein-1
An upregulator of SMN protein -
GC50181
CW 008
PKA signaling activator; promotes osteogenesis from hMSCs
-
GC43341
Cyclic GMP
鸟苷-3ˊ,5ˊ-环磷酸一钠盐
A second messenger
-
GC68923
Cyclocurcumin
Cyclocurcumin 是一种有效的 p38α 抑制剂。Cyclocurcumin 具有抗风湿、抗血管收缩和抗氧化活性。
-
GC30057
D-JNKI-1 (AM-111)
AM-111; XG-102
D-JNKI-1 (AM-111) (AM-111) 是一种高效且可渗透细胞的 JNK 肽抑制剂。 -
GC15187
Dabrafenib (GSK2118436)
达拉非尼; GSK2118436A; GSK2118436
A Raf kinase inhibitor -
GC12486
Dabrafenib Mesylate (GSK-2118436)
甲磺酸达拉非尼; GSK2118436 Mesylate; GSK 2118436B
A Raf kinase inhibitor -
GC47166
Dabrafenib-d9
达帕菲尼杂质,GSK2118436A-d9; GSK2118436-d9
An internal standard for the quantification of dabrafenib -
GN10336
Daphnetin
瑞香素; 7,8-Dihydroxycoumarin
A coumarin derivative with diverse biological activities -
GC68937
Darizmetinib
Darizmetinib 是一种丝裂原活化蛋白激酶激酶 (MAP2K) 的抑制剂。
-
GC14114
DB07268
2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺,DB 07268;DB-07268
A potent inhibitor of JNK1 -
GC15477
DBM 1285 dihydrochloride
p38 MAPK inhibitor
-
GC16795
DCA
二氯乙酸钠
DCA 是癌细胞中的代谢调节剂';具有抗癌活性的线粒体。 DCA 抑制 PDHK,导致肿瘤微环境中的乳酸减少。 DCA 增加活性氧 (ROS) 生成并促进癌细胞凋亡。 DCA 也可作为 NKCC 抑制剂。 -
GC72910
DD1
DD1蛋白酶体抑制剂,靶向急性髓系白血病(AML)凋亡过程中Bax的激活和P70S6K的降解。
-
GC18666
Debromohymenialdisine
DBH, SKF 108753
An inhibitor of Chk1 and Chk2 -
GC35832
Dehydrocorydaline chloride
盐酸脱氢紫堇碱; 13-Methylpalmatine chloride
An alkaloid with diverse biological activities -
GC16214
DEL-22379
N-[2,3-二氢-3-[(5-甲氧基-1H-吲哚-3-基)亚甲基]-2-氧代-1H-吲哚-5-基]-1-哌啶丙酰胺
An inhibitor of ERK dimerization -
GC32254
Deltonin
三角叶薯蓣皂苷
Deltonin是从盾叶薯蓣中得到的甾体皂苷,能够抑制ERK1/2和AKT的活化,具有抗肿瘤的活性。 -
GC12824
Dibutyryl-cAMP, sodium salt
Dibutyryl cAMP sodium salt; DBcAMP sodium salt
Dibutyryl-cAMP, sodium salt,又称为Bucladesine,是一种细胞膜可透性环核苷酸类似物,能模拟内源性cAMP的作用,并作为磷酸二酯酶抑制剂。 -
GC38319
Dihydrocaffeic acid
二氢咖啡酸; 3,4-Dihydroxy-benzenepropanoic acid
A polyphenol with diverse biological activities -
GC31697
Dilmapimod (SB-681323)
度马莫得; SB-681323; GW 681323
Dilmapimod (SB-681323,GW 681323) is a potent p38 MAPK inhibitor that potentially suppresses inflammation in chronic obstructive pulmonary disease. -
GC47237
Dipyridamole-d16
A neuropeptide with diverse biological activities
-
GC30913
DLK-IN-1
DLK-IN-1是双亮氨酸拉链激酶(DLK,MAP3K12)的选择性抑制剂,其Ki值为3nM。DLK-IN-1保持着良好的中枢神经系统穿透能力,并且在脑内剂量过量后依旧耐受性良好,在阿尔兹海默症动物模型中有良好的活性。
-
GC61466
DMU-212
3,4,5,4'-四甲氧基二苯乙烯
DMU-212 is a methylated derivative of Resveratrol, with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities, which can induce mitotic arrest via induction of apoptosis and activation of extracellular-signal-regulated kinase1/2 (ERK1/2) protein. -
GC65298
DMX-5804
DMX-5804 is a potent, orally active and selective inhibitor of Mitogen-activated protein kinase kinase kinase kinase-4 (MAP4K4) with IC50 of 3 nM for human MAP4K4. DMX-5804 is more potent on human MAP4K4 with pIC50 of 8.55 than MINK1/MAP4K6 and TNIK/MAP4K7 with pIC50 of 8.18 and 7.96, respectively.
-
GC71195
DN-1289
DN-1289是一种口服活性和选择性的双亮氨酸拉链激酶(DLK;IC50=17 nM)和亮氨酸拉链携带激酶(LZK;IC5=40 nM)抑制剂。
-
GC69013
DS12881479
DS12881479 是一种有效的选择性 Mnk1 抑制剂,其 IC50 值为21 nM. DS12881479 可用于癌症研究。
-
GC69015
DS89002333
DS89002333 是一种口服有效的强效 PRKACA 抑制剂,其 IC50 值为 0.3 nM。DS89002333 在表达 DNAJB1-PRKACA 融合基因的 FL-HCC 患者源性异种移植模型中显示较好的抗肿瘤活性。DS89002333 可用于纤维化肝细胞癌 (FL-HCC) 的研究。
-
GC13244
DTP3
DTP3 TFA 是一种有效的选择性 GADD45β/MKK7 抑制剂。 DTP3 TFA 靶向 NF-κB 通路下游的一个重要的癌症选择性细胞存活模块。
-
GC38202
DTP3 TFA
DTP3 is a selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor and is able to restore MKK7/JNK activation. DTP3 inhibits cancer-selective NF-κB survival pathway.
-
GC73118
EB1
EB1是MNK激酶的抑制剂,ic50值分别为0.69 μM (MNK1)和9.4 μM (MNK2)。
-
GC64496
EF24
EF24是一种新型合成姜黄素类似物。
-
GC10030
EHop-016
A Rac1 and Rac3 inhibitor
-
GC70927
Emprumapimod
Emprumapimod (PF-07265803)是一种有效的口服选择性p38α MAPK抑制剂,可直接抑制lps诱导的RPMI-8226细胞产生IL-6 (IC50=100 pM)。
-
GC70928
Emprumapimod hydrochloride
Emprumapimod hydrochloride是一种口服活性和选择性的p38α MAPK抑制剂。
-
GC69064
Endothelin-1 (1-31) (Human) TFA
Endothelin-1 (1-31) (Human) TFA 是一种有效的血管收缩剂和血压升高剂。Endothelin-1 (1-31) (Human) TFA 来源于 chymase 对大 ET-1 的选择性水解。
-
GC43610
Enniatin A1
恩镰孢菌素 A1
An ionophore antibiotic -
GC17693
Enniatin B
恩镰孢菌素 B
A natural inhibitor of Pdr5p in yeast -
GC43611
Enniatin B1
恩镰孢菌素 B1
An antibiotic ionophore -
GC10403
EO 1428
EO 1428, p38 MAP Kinase Inhibitor VIII, p38 Mitogen-activated Protein Kinase Inhibitor VIII
An inhibitor of p38α and p38β MAP kinases -
GC43624
ERK Inhibitor
Extracellular Regulated Kinase Inhibitor
An ERK inhibitor -
GC33206
ERK-IN-1
ERK-IN-1(化合物 B)是一种可口服的 ERK1 和 ERK2 抑制剂,用于治疗以激活 MAPK 通路突变为特征的增殖性疾病。该活性尤其与 KRAS 突变 NSCLC、BRAF 突变 NSCLC、KRAS 突变胰腺癌、KRAS 突变结直肠癌 (CRC) 和 KRAS 突变卵巢癌的治疗有关。 ERK-IN-1 hydrochloride 也可以抑制 RAF。
-
GC62229
ERK-IN-3
ERK-IN-3
ASN007(ERAS 007, ERK-IN-3) is a potent and orally active inhibitor of ERK. ERK-IN-3 inhibits ERK1/2 with 2 nM IC50 values. ERK-IN-3 can be used for the research of cancers driven by RAS mutations. -
GC63459
ERK-IN-3 benzenesulfonate
ERK-IN-3 benzenesulfonate
ERK-IN-3 benzenesulfonate 是一种有效和具有口服活性的 ERK 抑制剂。 ERK-IN-3 benzenesulfonate 以较低的 IC50 值抑制 ERK1/2。 ERK-IN-3 benzenesulfonate 可用于研究由 RAS 突变驱动的癌症。 -
GC65510
ERK1/2 inhibitor 1
ERK1/2 inhibitor 1 是一种有效的,口服生物可利用的 ERK1/2 抑制剂,在 1 nM 时抑制 ERK1 达60%,抑制 ERK2 的 IC50 为 3.0 nM。
-
GC60812
ERK1/2 inhibitor 2
An ERK inhibitor
-
GC67905
ERK1/2 inhibitor 7
ERK1/2 inhibitor 7 是一种有效的 ERK 抑制剂,对 ERK2 IC50 为 0.94 nM。
-
GC73481
ERK1/2 inhibitor 9
ERK1/2 inhibitor 9(探针1)是共价ERK1/2抑制剂。
-
GC32796
ERK5-IN-1
ERK5-IN-1
An ERK5 inhibitor